By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Meridian Bioscience today reported an 8 percent hike in its fiscal first-quarter revenues helped along by its illumigene molecular diagnostic franchise.

For the three months ended Dec. 31, 2011, sales rose to $40.3 million, compared to $37.3 million in the year-ago period, but fell short of consensus analyst estimates of $43.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.